Credit Suisse Ag Frequency Therapeutics, Inc. Transaction History

Credit Suisse Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.46 - $2.55 $24 - $43	-17 Reduced 16.04%	89 $0
Q2 2022 Aug 12, 2022	BUY	$1.03 - $2.03 $109 - $215	106 New	106 $0
Q4 2021 Feb 14, 2022	SELL	$4.95 - $7.11 $83,278 - $119,618	-16,824 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.96 - $9.25 $3,473 - $4,615	499 Added 3.06%	16,824 $118,000
Q2 2021 Aug 16, 2021	SELL	$8.05 - $11.61 $37,295 - $53,789	-4,633 Reduced 22.11%	16,325 $162,000
Q1 2021 May 14, 2021	SELL	$7.99 - $55.01 $100,042 - $688,780	-12,521 Reduced 37.4%	20,958 $198,000
Q4 2020 Feb 12, 2021	BUY	$18.65 - $40.0 $624,383 - $1.34 Million	33,479 New	33,479 $1.18 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.